BCLS Acquisition Corp. (Nasdaq: BLSA) is a blank-check company sponsored by Bain Capital Life Sciences, the life sciences-focused investment arm of Bain Capital. The SPAC completed its initial public offering in 2021 and targets acquisition opportunities in the healthcare and life sciences sector, consistent with the sponsor's core investment focus. The 10-Q filed on August 12, 2022 reflects the company's continued search for a suitable business combination target, with no definitive agreement announced as of that reporting period. BLSA remains one of several healthcare-focused SPACs brought to market during the 2020–2022 SPAC cycle by established institutional sponsors. Visit SpacDesk and sign up for full access to BLSA filings, deal timelines, and sponsor track-record data.